Early Detection of Mental Disorders in Adolescents With Chronic Pain: Creation of a Screening Tool for Use by the General Practitioner (REPERADO)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
First part : creation of a screening tool. After detailed interviews with chronic pain experts and bibliographic research, a screening tool for mental disorders in chronically painful adolescents has been designed for use by the general practitioner. This tool is composed of 10 questions, making up a score of 10 points. The tool will be compared to two screening tools used in different clinical contexts, the HAD scale and the RPPS scale, in order to determine a positivity threshold. There is only one center participating in the research, the Centre de la Douleur et de la migraine de l'hôpital Trousseau (Trousseau Hospital Pain Center). Parents' consent is required for participation. For this assessment, the adolescents (between 10 and 18 years old) that see a doctor at the Centre de la douleur, will be asked to fill up the questionnaires in the waiting room. The filling of the questionnaire takes a few minutes. At the end of the appointment, the doctor will read the questionnaire to check that all elements have been addressed during the appointment.
Second part : focus group on the questionnaire: 5 to 10 adolescents will participate in a discussion group lead by a paediatrician and a psychologist from the Centre de la Douleur de Trousseau. Two groups will be organized, the length of the group discussion being one hour. These focus groups will explore the adolescents' perception of the questionnaire and of different elements of the screening. The group will undergo full transcription. The verbatim will be anonymous and will be analysed through qualitative methods.
The data will help designing a guidebook for the clinician explaining the main points in screening for mental disorders in chronic pain adolescent patients.
A validation study for the screening tool will be eventually carried out after the completion of this preliminary study.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75012
- Centre de la douleur et de la migraine-Hôpital Trousseau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient from 10 to 18 years old
- chronic pain (existing for more than 3 months or longer than tissue repair time)
- first consultation in the service
- Collection of the written consent of the holders of parental authority and agreement of the adolescent
- Adolescents able to understand the questionnaire and the purpose of the study
- Affiliation to a social security scheme or beneficiary
Exclusion Criteria:
Exclusion Criteria :
- Decompensated physical or psychological pathology requiring urgent medical treatment
- Heavy psychological pathology preventing the adolescent's understanding of the study
- Patient benefiting from State Medical Aid
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Focus group with chronically painful adolescents
Adolescents with chronic pain
|
5 to 10 adolescents will participate in a discussion group lead by a paediatrician and a psychologist from the Centre de la Douleur de Trousseau.
Two groups will be organized, the length of the group discussion being one hour.
These focus groups will explore the adolescents' perception of the questionnaire and of different elements of the screening.
The group will undergo full transcription.
The verbatim will be anonymous and will be analysed through qualitative methods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screening questionnaire score
Time Frame: Baseline visit
|
A new Screening questionnaire elaborated beforehand by the study will be answered by patients in order to detect psychological suffering in chronically painful adolescents The screening questionnaire consists in 10 items (yes/no response format)
|
Baseline visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression (HAD) score
Time Frame: Baseline visit
|
Patients complete a Hospital Anxiety and Depression (HAD) scale questionnaire
|
Baseline visit
|
|
Pediatric Pain Screening Tool (PPST) score
Time Frame: Baseline visit
|
Patients complete a Pediatric Pain Screening Tool questionnaire
|
Baseline visit
|
|
Participants feedback
Time Frame: up to 3 months upon recuitment
|
Focus group questions will provide descriptions of patients' experiences with the questionnaire
|
up to 3 months upon recuitment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexandra LOISEL, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP200623
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.